Page last updated: 2024-08-21

azomycin and Delayed Hypersensitivity

azomycin has been researched along with Delayed Hypersensitivity in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Arrese-Muñoz, I; Aznar, ML; Bosch-Nicolau, P; Espinosa-Pereiro, J; Franco-Jarava, C; Molina, I; Oliveira-Souto, I; Pou, D; Roure, S; Salvador, F; Sánchez-Montalvá, A; Serre-Delcor, N; Sulleiro, E; Treviño, B; Valerio, L1
Aparicio, G; Artaza, MÁ; Ferrer, B; García-Prat, M; Martínez-Gallo, M; Molina, I; Sala-Cunill, A; Salvador, F; Sánchez-Montalvá, A; Sao Avilés, A; Viñas, L1
Bahk, TJ; Daniels, MD; Engman, DM; Giafis, N; Hyland, KV; Leon, JS; Wang, K; Woods, LM1
Neaderland, MH; Rockwell, S1
Irvin, CG; Neaderland, MH; Rockwell, S1
Córdoba, JC; Solórzano, E; Souto Maior, I; Teixeira, AR1

Other Studies

6 other study(ies) available for azomycin and Delayed Hypersensitivity

ArticleYear
Association of HLA-B∗35 and moderate or severe cutaneous reactions secondary to benznidazole treatment in chronic chagas disease.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022, Volume: 28, Issue:6

    Topics: Adult; Chagas Disease; Female; HLA-B Antigens; Humans; Hypersensitivity, Delayed; Male; Middle Aged; Nitroimidazoles; Skin

2022
Evaluation of cytokine profile and HLA association in benznidazole related cutaneous reactions in patients with Chagas disease.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-01, Volume: 61, Issue:11

    Topics: Adult; Alleles; Chagas Disease; Cytokines; Drug Eruptions; Female; Genes, MHC Class I; Genes, MHC Class II; HLA-B Antigens; Humans; Hypersensitivity, Delayed; Interleukin-10; Interleukin-5; Male; Nitroimidazoles; Prospective Studies; Skin; Th2 Cells; Trypanocidal Agents; Trypanosoma cruzi

2015
Modulation of autoimmunity by treatment of an infectious disease.
    Infection and immunity, 2007, Volume: 75, Issue:7

    Topics: Animals; Autoimmune Diseases; Autoimmunity; Chagas Cardiomyopathy; Humans; Hypersensitivity, Delayed; Immunosuppressive Agents; Male; Mice; Myocarditis; Myosins; Nitroimidazoles; Treatment Outcome; Trypanosoma cruzi

2007
Suppression of cell-mediated immunity by misonidazole.
    International journal of radiation biology and related studies in physics, chemistry, and medicine, 1982, Volume: 42, Issue:2

    Topics: Animals; Dinitrofluorobenzene; Drug Hypersensitivity; Female; Hypersensitivity, Delayed; Immunity, Cellular; Mice; Mice, Inbred BALB C; Mice, Nude; Misonidazole; Nitroimidazoles; Specific Pathogen-Free Organisms

1982
Inhibition of delayed hypersensitivity by metronidazole and misonidazole.
    International journal of radiation oncology, biology, physics, 1983, Volume: 9, Issue:5

    Topics: Animals; Dinitrofluorobenzene; Drug Hypersensitivity; Female; Hypersensitivity, Delayed; Male; Metronidazole; Mice; Mice, Inbred BALB C; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Specific Pathogen-Free Organisms

1983
Chagas' disease: lymphoma growth in rabbits treated with Benznidazole.
    The American journal of tropical medicine and hygiene, 1990, Volume: 43, Issue:2

    Topics: Animals; Antibodies, Protozoan; Chagas Cardiomyopathy; Chagas Disease; Female; Hypersensitivity, Delayed; Immunity, Cellular; Intradermal Tests; Liver; Lymphoma, Non-Hodgkin; Male; Molecular Structure; Myocardium; Nitroimidazoles; Rabbits; Trypanocidal Agents; Trypanosoma cruzi

1990